Literature DB >> 22646917

Interaction of dopamine transporter (DAT1) genotype and maltreatment for ADHD: a latent class analysis.

James J Li1, Steve S Lee.   

Abstract

BACKGROUND: Although the association of the dopamine transporter (DAT1) gene and attention-deficit/hyperactivity disorder (ADHD) has been widely studied, far less is known about its potential interaction with environmental risk factors. Given that maltreatment is a replicated risk factor for ADHD, we explored the interaction between DAT1 and maltreatment with ADHD symptoms defined dimensionally and using latent class analysis (LCA).
METHOD: We tested the association of the 40 base-pair variable number of tandem repeats polymorphism in DAT1, maltreatment, and their interaction in 2,488 boys and girls from the National Longitudinal Study of Adolescent Health.
RESULTS: In boys, ADHD symptoms were optimally defined by four classes (Combined, Hyperactive/Impulsive, Inattentive, and Normal), whereas in girls, ADHD symptoms were defined by three classes (Combined, Combined-Mild, Normal). A significant DAT1 × maltreatment interaction revealed that maltreated girls homozygous for the 10-repeat allele had more symptoms of ADHD, and were also 2.5 times more likely to be classified in the Combined ADHD group than in the Normal Group.
CONCLUSIONS: The underlying structure of ADHD symptoms differed between boys and girls and DAT1 interacted with maltreatment to predict ADHD symptoms and ADHD status derived from LCA. Interactive exchanges between maltreatment and DAT1 for ADHD symptoms, and their implications for intervention, are discussed.
© 2012 The Authors. Journal of Child Psychology and Psychiatry © 2012 Association for Child and Adolescent Mental Health.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22646917      PMCID: PMC3445417          DOI: 10.1111/j.1469-7610.2012.02563.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  38 in total

1.  Assessing adult ADHD using a self-report symptom checklist.

Authors:  J P O'Donnell; K K McCann; S Pluth
Journal:  Psychol Rep       Date:  2001-06

Review 2.  Maternal neglect: oxytocin, dopamine and the neurobiology of attachment.

Authors:  L Strathearn
Journal:  J Neuroendocrinol       Date:  2011-11       Impact factor: 3.627

Review 3.  Sensitivity to the depressogenic effect of stress and HPA-axis reactivity in adolescence: a review of gender differences.

Authors:  Albertine J Oldehinkel; Esther M C Bouma
Journal:  Neurosci Biobehav Rev       Date:  2010-10-30       Impact factor: 8.989

4.  A meta-analytic review of gender differences in ADHD.

Authors:  J Gershon
Journal:  J Atten Disord       Date:  2002-01       Impact factor: 3.256

5.  Latent class analysis of ADHD and comorbid symptoms in a population sample of adolescent female twins.

Authors:  R J Neuman; A Heath; W Reich; K K Bucholz; L Sun; R D Todd; J J Hudziak
Journal:  J Child Psychol Psychiatry       Date:  2001-10       Impact factor: 8.982

6.  Validity of DSM-IV subtypes of attention-deficit/hyperactivity disorder: a family study perspective.

Authors:  S V Faraone; J Biederman; D Friedman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-03       Impact factor: 8.829

7.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

Authors:  Jonathan Mill; Philip Asherson; Clare Browes; Ursula D'Souza; Ian Craig
Journal:  Am J Med Genet       Date:  2002-12-08

Review 8.  The neurobiological consequences of early stress and childhood maltreatment.

Authors:  Martin H Teicher; Susan L Andersen; Ann Polcari; Carl M Anderson; Carryl P Navalta; Dennis M Kim
Journal:  Neurosci Biobehav Rev       Date:  2003 Jan-Mar       Impact factor: 8.989

9.  Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.

Authors:  Tatiana Roman; Claudia Szobot; Silvia Martins; Joseph Biederman; Luis A Rohde; Mara H Hutz
Journal:  Pharmacogenetics       Date:  2002-08

Review 10.  The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view.

Authors:  Andrew S Rowland; Catherine A Lesesne; Ann J Abramowitz
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002
View more
  7 in total

1.  Predicting childhood effortful control from interactions between early parenting quality and children's dopamine transporter gene haplotypes.

Authors:  Yi Li; Michael J Sulik; Nancy Eisenberg; Tracy L Spinrad; Kathryn Lemery-Chalfant; Daryn A Stover; Brian C Verrelli
Journal:  Dev Psychopathol       Date:  2015-04-30

Review 2.  Deviations from the expectable environment in early childhood and emerging psychopathology.

Authors:  Kathryn L Humphreys; Charles H Zeanah
Journal:  Neuropsychopharmacology       Date:  2014-07-07       Impact factor: 7.853

3.  Genetic associations between ADHD and dopaminergic genes (DAT1 and DRD4) VNTRs in Korean children.

Authors:  Jun Ho Hong; In Wook Hwang; Myung Ho Lim; Ho Jang Kwon; Han Jun Jin
Journal:  Genes Genomics       Date:  2018-08-11       Impact factor: 1.839

4.  Item Response Theory Analysis of ADHD Symptoms in Children With and Without ADHD.

Authors:  James J Li; Steven P Reise; Andrea Chronis-Tuscano; Amori Yee Mikami; Steve S Lee
Journal:  Assessment       Date:  2015-07-01

5.  ADHD among adolescents with intellectual disabilities: pre-pathway influences.

Authors:  Cameron L Neece; Bruce L Baker; Steve S Lee
Journal:  Res Dev Disabil       Date:  2013-05-10

6.  Child maltreatment, impulsivity, and antisocial behavior in African American children: Moderation effects from a cumulative dopaminergic gene index.

Authors:  Eric L Thibodeau; Dante Cicchetti; Fred A Rogosch
Journal:  Dev Psychopathol       Date:  2015-11

7.  Polygenic risk score, psychosocial environment and the risk of attention-deficit/hyperactivity disorder.

Authors:  Søren D Østergaard; Betina B Trabjerg; Thomas D Als; Clara Albiñana Climent; Florian Privé; Bjarni Jóhann Vilhjálmsson; Marie Bækvad-Hansen; Jonas Bybjerg-Grauholm; David M Hougaard; Merete Nordentoft; Thomas Werge; Ditte Demontis; Preben B Mortensen; Anders D Børglum; Ole Mors; Esben Agerbo
Journal:  Transl Psychiatry       Date:  2020-10-02       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.